Description

MAHAMAYA LIFESCIENCES LIMITED equity shares will be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective December 1, 2025.

Summary

BSE has announced that the equity shares of MAHAMAYA LIFESCIENCES LIMITED (Scrip Code: 544611) will be transferred from the Trade for Trade segment (MT Group) to the Rolling segment (M Group) effective December 1, 2025. This change follows the company’s SME IPO listing and represents a transition to normal trading operations.

Key Points

  • Company: MAHAMAYA LIFESCIENCES LIMITED (SME IPO)
  • Scrip Code: 544611
  • Current Segment: Trade for Trade (MT Group)
  • New Segment: Rolling Settlement (M Group)
  • Effective Date: Monday, December 1, 2025
  • Notice Reference: Continuation of Exchange Notice No. 20251117-58 dated November 17, 2025
  • Contact: Mr. Anurag Jain, Tel: 022-2272 8822

Regulatory Changes

The equity shares will transition from the Trade for Trade settlement mechanism to Rolling settlement, which allows for standard T+1 settlement cycles instead of the more restrictive trade-for-trade framework typically applied to newly listed SME stocks.

Compliance Requirements

Trading members should:

  • Note the segment change effective December 1, 2025
  • Update their systems to reflect the new group classification (M Group)
  • Contact Mr. Anurag Jain for further details or clarifications
  • Review the listing notice available on BSE website

Important Dates

  • November 17, 2025: Original notice issued (Notice No. 20251117-58)
  • November 18, 2025: Current notice date
  • December 1, 2025: Effective date for transfer to Rolling segment (M Group)

Impact Assessment

This change is positive for market participants as it improves liquidity and trading flexibility for MAHAMAYA LIFESCIENCES shares. The transition from Trade for Trade to Rolling settlement indicates the stock has met BSE’s requirements for normal trading operations. Investors will benefit from standard settlement cycles and potentially improved liquidity, though the stock will still be classified under M Group which may have certain restrictions compared to other groups.

Impact Justification

Segment change from Trade for Trade to Rolling settlement affects trading mechanism for MAHAMAYA LIFESCIENCES but is a standard progression for SME IPO stocks. Medium impact for traders and investors in this scrip.